171 related articles for article (PubMed ID: 37667220)
1. TET2 inhibits the proliferation and metastasis of lung adenocarcinoma cells via activation of the cGAS-STING signalling pathway.
Cheng G; Wu J; Ji M; Hu W; Wu C; Jiang J
BMC Cancer; 2023 Sep; 23(1):825. PubMed ID: 37667220
[TBL] [Abstract][Full Text] [Related]
2. LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non-small cell lung cancer.
Gao Y; Zhang N; Zeng Z; Wu Q; Jiang X; Li S; Sun W; Zhang J; Li Y; Li J; He F; Huang Z; Zhang J; Gong Y; Xie C
Clin Transl Med; 2022 Apr; 12(4):e792. PubMed ID: 35415876
[TBL] [Abstract][Full Text] [Related]
3. Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
Wu Q; Li R; Wang QX; Zhang MY; Liu TT; Qu YQ
J Transl Med; 2022 Jun; 20(1):260. PubMed ID: 35672776
[TBL] [Abstract][Full Text] [Related]
4. RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma.
Jiang X; Li Y; Zhang N; Gao Y; Han L; Li S; Li J; Liu X; Gong Y; Xie C
Cell Biosci; 2021 Apr; 11(1):74. PubMed ID: 33858512
[TBL] [Abstract][Full Text] [Related]
5. Entanglement of Methylation Changes and cGAS-STING Signaling in Non-Small-Cell Lung Cancer.
Hao F
Comb Chem High Throughput Screen; 2023; 26(1):224-235. PubMed ID: 35585823
[TBL] [Abstract][Full Text] [Related]
6. The RNA-binding protein PCBP1 represses lung adenocarcinoma progression by stabilizing DKK1 mRNA and subsequently downregulating β-catenin.
Zheng Y; Zhou Z; Wei R; Xiao C; Zhang H; Fan T; Zheng B; Li C; He J
J Transl Med; 2022 Jul; 20(1):343. PubMed ID: 35907982
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of lncRNA A2M-AS1 inhibits cell growth and aggressiveness
Guo H; Li T; Peng C; Mao Q; Shen B; Shi M; Lu H; Xiao T; Yang A; Liu Y
Hum Exp Toxicol; 2022; 41():9603271221138971. PubMed ID: 36461613
[TBL] [Abstract][Full Text] [Related]
8. DNA repair/recombination protein 54L promotes the progression of lung adenocarcinoma by activating mTORC1 pathway.
Liu C; Ren W; Zhang Z; Guan J
Hum Cell; 2023 Jan; 36(1):421-433. PubMed ID: 36454390
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
[TBL] [Abstract][Full Text] [Related]
10. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
Ma S; Wang X; Zhang Z; Liu D
Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
[TBL] [Abstract][Full Text] [Related]
11. STING activation in TET2-mutated hematopoietic stem/progenitor cells contributes to the increased self-renewal and neoplastic transformation.
Xie J; Sheng M; Rong S; Zhou D; Wang C; Wu W; Huang J; Sun Y; Wang Y; Chen P; Wu Y; Wang Y; Wang L; Zhou BO; Huang X; Walsh CP; Bohlander SK; Huang J; Wang X; Xu GL; Gao H; Shi Y
Leukemia; 2023 Dec; 37(12):2457-2467. PubMed ID: 37816954
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of TET Family Gene Expression and 5-Hydroxymethylcytosine as Potential Epigenetic Markers in Non-small Cell Lung Cancer.
Alrehaili AA; Gharib AF; Alghamdi SA; Alhazmi A; Al-Shehri SS; Hagag HM; Alsaeedi FA; Alhuthali HM; Raafat N; Etewa RL; Elsawy WH
In Vivo; 2023; 37(1):445-453. PubMed ID: 36593050
[TBL] [Abstract][Full Text] [Related]
14. Increased activation of cGAS-STING pathway enhances radiosensitivity of non-small cell lung cancer cells.
Xue A; Shang Y; Jiao P; Zhang S; Zhu C; He X; Feng G; Fan S
Thorac Cancer; 2022 May; 13(9):1361-1368. PubMed ID: 35429143
[TBL] [Abstract][Full Text] [Related]
15. Ten-eleven translocation 2 demethylates the
Li X; Wu C; Shen Y; Wang K; Tang L; Zhou M; Yang M; Pan T; Liu X; Xu W
J Biol Chem; 2018 Jun; 293(26):10059-10070. PubMed ID: 29773648
[TBL] [Abstract][Full Text] [Related]
16. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
Poole CJ; Lodh A; Choi JH; van Riggelen J
Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
[TBL] [Abstract][Full Text] [Related]
17. CCNE1 Promotes Progression and is Associated with Poor Prognosis in Lung Adenocarcinoma.
Ma G; Yang L; Dong J; Zhang L
Curr Pharm Biotechnol; 2022; 23(9):1168-1178. PubMed ID: 34792009
[TBL] [Abstract][Full Text] [Related]
18. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
[TBL] [Abstract][Full Text] [Related]
19. Chenodeoxycholic acid inhibits lung adenocarcinoma progression via the integrin α5β1/FAK/p53 signaling pathway.
Shen D; Zeng Y; Zhang W; Li Y; Zhu J; Liu Z; Yan Z; Huang JA
Eur J Pharmacol; 2022 May; 923():174925. PubMed ID: 35364069
[TBL] [Abstract][Full Text] [Related]
20. TXNDC9 knockdown inhibits lung adenocarcinoma progression by targeting YWHAG.
Wang J; Pan X; Li J; Zhao J
Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35485284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]